Grail GRAL
NASDAQ GRAL
$80.77 +0.82 (+1.03%)
At close: Sep 18, 2026 · 4:00 PM EDT

Grail (GRAL) Net Margin Growth (1y) (2024 - 2026)

Analysis

Grail (GRAL) Net Margin Growth (1y) (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn 958.00
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn 25.00
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn 126.00
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn 718.00
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn 1,584.00
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn 28,488.00
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn 1,399.00
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn 773.00
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn 2,082.00
10 Grail 3.61 Bn 2.75 Bn 21.34 Mn 7,398.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7,398.00
Mar 31, 2026 10,513.00
Sep 30, 2025 19,284.00
Jun 30, 2025 463,814.00
Mar 31, 2025 48,564.00
Dec 31, 2024 -5,119.00
Sep 30, 2024 386,327.00
Jun 30, 2024 -409,756.00